Myofrastand

It was a profound honor to organize this The Global Health Innovation Summit, 2026 in collaboration with Bergen New Bridge Medical Center Foundation. This gathering brought together physicians and scientists to explore the latest clinical and scientific advancements in Alzheimer’s disease and dementia. 🧠✨

Our mission was clear: to bridge the gap between complex research and our community by providing credible, science-based information grounded in published data and logical analysis. 🔬

A Heartfelt Thank You to Our Collaborators!
This event would not have been possible without the support of an incredible team:

Partnership: My deepest gratitude to Bergen New Bridge Medical Center and their visionary CEO, Mrs. Deborah Visconi, and her entire team for their unwavering support in making this summit a reality.

Dedication: A special thank you to Dr. Nanette Bishopric and Dr. Lukshmi Puttanniah for adjusting their demanding schedules to support this initiative. Your commitment to our community and caregivers is truly inspiring.

Commitment: Thank you, Dr. Paula Waziry, for traveling from Florida to enrich our dialogue with your vital expertise.

Innovation: Mrs. Ilham Atir, thank you for your invaluable contributions regarding the novel, FDA-cleared Alzheimer’s biomarker tests now available at New Bridge Medical Center.

The Future: Dr. Filipe Litaiff, your insights into the role of Artificial Intelligence in early detection highlight the incredible promise of technology in clinical care. 🤖

What’s Next?
Throughout this week, I will be sharing highlights and key insights from our discussions. Whether you are a fellow scientist or a member of the broader community, I invite you to follow along as we dive deeper into the data and stories that defined this special day.

Thank you to everyone who attended and contributed. Together, we are advancing the conversation on public health and cognitive care.

HealthcareLeadership NewBridgeMedical